Jane Street’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Jane Street’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,000	Closed	-$336K	–	5065
2016 Q4	$336K	Sell	27,000 -50,400	-65%	-$607K	﹤0.01%	3247
2016 Q3	$1.06M	Buy	77,400 +35,700	+86%	+$358K	0.01%	1878
2016 Q2	$308K	Buy	+41,700	New	+$313K	﹤0.01%	3294
2015 Q3	–	Sell	-193,600	Closed	-$1.6M	–	4505
2015 Q2	$1.6M	Buy	193,600 +142,700	+280%	+$1.26M	0.01%	1153
2015 Q1	$419K	Sell	50,900 -17,100	-25%	-$126K	﹤0.01%	2215
2014 Q4	$467K	Buy	+68,000	New	+$425K	﹤0.01%	1536

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Jane Street's ARIA Position: Q1 2017 in Review

Jane Street sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,340 shares — an estimated $377K sold.

Jane Street first reported a position in ARIA in Q4 2013 and held it in 9 quarters. The position peaked at $1.31M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Jane Street reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Jane Street sold 30,340 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $377K.
Jane Street first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 9 quarters.
Jane Street's Ariad Pharmaceuticals Inc position peaked at $1.31M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Jane Street's 13F filing for Q1 2017, filed 15 May 2017.